| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.12B | +0.7% |
| Cost of Revenue | $5.38B | -1.3% |
| Gross Profit | $741.4M | +18.8% |
| R&D Expense | $159.0M | +2.3% |
| SG&A Expense | $387.1M | +5.5% |
| Operating Income | $241.4M | +64.7% |
| Interest Expense | $186.0M | -7.8% |
| Pre-tax Income | $62.8M | +356.3% |
| Income Tax | $27.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $552.9M | +6.3% |
| Accounts Receivable | $709.1M | -13.4% |
| Inventory | $442.5M | -8.4% |
| Current Assets | $1.91B | -4.6% |
| Total Assets | $5.06B | -5.5% |
| Current Liabilities | $1.18B | -2.2% |
| Long-term Debt | $2.58B | -6.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $455.4M | +15.0% |
| Capital Expenditures | $248.0M | +27.4% |
| Investing Cash Flow | -$254.8M | -38.1% |
| Financing Cash Flow | -$156.2M | +24.0% |
| Free Cash Flow | $207.4M | +2.9% |
| +205.5% |
| Net Income | $35.0M | +204.2% |
| EPS (Basic) | $0.29 | +200.0% |
| EPS (Diluted) | $0.29 | +200.0% |
| Total Liabilities |
| $4.50B |
| -5.4% |
| Stockholders' Equity | $562.8M | -7.0% |